Management of localized buccal dehiscence defect with allografts and acellular dermal matrix.
Sang Hoon Park, Hom‐Lay Wang
Abstract
Sang Hoon Park, Hom‐Lay Wang
Abstract
This case series presents the use of acellular dermal matrix (ADM) as a barrier membrane in reconstructing non-spacemaking buccal dehiscences associated with simultaneous implant placement in locally deficient ridges. Five sites in four healthy nonsmoking patients were treated with a combination of the mucogingival pouch flap technique, sandwiched layering of mineralized human cancellous and cortical bone grafts, and ADM as a barrier membrane. Three sites encountered 2 to 4 mm of membrane exposure after 2 weeks of healing time. However, all sites were completely covered at 3 months. None of the cases exhibited implant exposure throughout the entire healing period. At the 6-month re-entry surgery, ADM-assisted guided bone regeneration achieved a mean of 86.5% height gain and critical bone thickness of 1.8 mm or greater, with clinical bone density equivalent to that of the native bone.
OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
This case series presents the use of acellular dermal matrix (ADM) as a barrier membrane in reconstructing non-spacemaking buccal dehiscences associated with simultaneous implant placement in locally deficient ridges. Five sites in four healthy nonsmoking patients were treated with a combination of the mucogingival pouch flap technique, sandwiched layering of mineralized human cancellous and cortical bone grafts, and ADM as a barrier membrane. Three sites encountered 2 to 4 mm of membrane exposure after 2 weeks of healing time. However, all sites were completely covered at 3 months. None of the cases exhibited implant exposure throughout the entire healing period. At the 6-month re-entry surgery, ADM-assisted guided bone regeneration achieved a mean of 86.5% height gain and critical bone thickness of 1.8 mm or greater, with clinical bone density equivalent to that of the native bone.
Key concepts: Barrier membrane, Buccal administration, Dehiscence, Medicine, Implant, Dentistry, Wound dehiscence, Surgery